Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.1750
-0.1050 (-4.61%)
NASDAQ· Last Trade: Jul 31st, 2:34 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors